| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹73.81 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹73.81 Cr |
| Fresh Issue | ₹46.31 Cr |
| Offer for Sale | ₹23.79 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน113.00-119.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | SHRIAHIMSA |
| Registrar | Cameo Corporate Services Ltd. |
| Lead Managers | Srujan Alpha Capital Advisors... |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,200 shares and in multiples thereof
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.
The company's products find its application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits.
The company's product portfolio includes the following:-
Natural Caffeine:Extracted from seeds of various plants like coffee and tea, their caffeine is used in energy drinks, soft drinks, cosmetics, and pharmaceuticals.
Green Coffee Bean Extract:Sourced from unroasted green coffee seeds, this extract is rich in chlorogenic acid, known for its antioxidant properties and potential weight loss benefits.
The company exports its products to the USA, Germany, South Korea, the UK, Thailand, etc.
For the period ending September 30, 2024, revenue from exports (including deemed exports) of the Company’s products was โน3,530.91 lakhs, โน7,463.71 lakhs, and โน9,988.01 lakhs for Fiscal 2023 and โน5,633.50 lakhs for Fiscal 2022.
The manufacturing unit is situated in Jaipur, Rajasthan.
The manufacturing facility complies with 2015 [Quality Management System], 2018 ISO 22000 [Food Safety Management System], 2018 ISO 45001 [Occupational Health & Safety Management System], 2015 ISO 14001 [Environmental Management System], HACCP, and GMP guidelines for superior quality.
As of March 2025, the company employed about 80 employees.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Investment in Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Pvt.Ltd. (SAHPL) for setting up a manufacturing unit at Sawarda, Jaipur, Rajasthan | 35.00 |
| 2 | General Corporate Purposes | 4.30 |
| 3 | Issue Expenses | 10.71 |
| Total | 50.00 |
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 111.39 | 103.15 | 74.13 | 40.34 |
| Total Income | 41.37 | 78.70 | 106.14 | 58.94 |
| Profit After Tax | 9.74 | 18.67 | 38.21 | 11.02 |
| NET Worth | 99.67 | 83.89 | 65.22 | 27.02 |
| Reserves and Surplus | 80.54 | 65.57 | 59.99 | 21.78 |
| Total Borrowing | 4.85 | 13.83 | 3.43 | 6.36 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 22.25% |
| ROCE | 25.69% |
| Debt / Equity | 0.07% |
| RoNW | 22.25% |
| PAT Margin | 23.91% |
| Price to Book Value | 2.60 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 9.76 | 8.35 |
| P/E (x) | 12.19 | 14.25 |
| Promoter Holding | 94.22% | 68.68% |
| Market Cap | โน277.63 Cr. | |